|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2006-10-12
|
|
pubmed:abstractText |
Artemisinin-containing therapies are highly effective against Plasmodium falciparum malaria. Insufficient numbers of tablets and inadequate package inserts result in sub-optimal dosing and possible treatment failure. This study reports the case of three, non-immune, expatriate workers with P. falciparum acquired in Africa, who failed to respond to artemisinin-based therapy. Sub-therapeutic dosing in accordance with the manufacturers' recommendations was the probable cause.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/17020598-10072142,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17020598-10402975,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17020598-10418762,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17020598-11083649,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17020598-11258214,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17020598-11487367,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17020598-11791958,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17020598-11891382,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17020598-12604519,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17020598-12625145,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17020598-12641403,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17020598-15275204,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17020598-15598255,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17020598-15814029,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17020598-8470777,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17020598-9210658,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17020598-9657513
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1475-2875
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
81
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:17020598-Adult,
pubmed-meshheading:17020598-Antimalarials,
pubmed-meshheading:17020598-Artemisinins,
pubmed-meshheading:17020598-Cote d'Ivoire,
pubmed-meshheading:17020598-Dose-Response Relationship, Drug,
pubmed-meshheading:17020598-Drug Labeling,
pubmed-meshheading:17020598-Ethanolamines,
pubmed-meshheading:17020598-Female,
pubmed-meshheading:17020598-Fluorenes,
pubmed-meshheading:17020598-Guidelines as Topic,
pubmed-meshheading:17020598-Guinea,
pubmed-meshheading:17020598-Humans,
pubmed-meshheading:17020598-Lactones,
pubmed-meshheading:17020598-Malaria, Falciparum,
pubmed-meshheading:17020598-Parasitemia,
pubmed-meshheading:17020598-Recurrence,
pubmed-meshheading:17020598-Risk,
pubmed-meshheading:17020598-Sesquiterpenes,
pubmed-meshheading:17020598-Sudan,
pubmed-meshheading:17020598-Switzerland,
pubmed-meshheading:17020598-Treatment Failure,
pubmed-meshheading:17020598-World Health Organization
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure?
|
|
pubmed:affiliation |
Travel and Migration Medicine Unit, Geneva University Hospital, Rue Micheli-du-Crest 24, 1211 Geneva 14, Switzerland. yves.jackson@hcuge.ch
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
